Furthermore, expression levels of type-I and -III collagen, fibronectin, and elastin were analyzed in keloid tissue spheroids treated with EP through immunohistochemistry, providing a comprehensive insight into the compound’s capacity to attenuate fibrosis and potentially offer a novel therapeutic avenue for keloid management. The gene discussed is ELN; the disease is keloid.